Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

First deuterated drug approved

A Correction to this article was published on 09 November 2017

This article has been updated

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Change history

  • 13 April 2018

    In the version of this article initially published, the drug BMS-986165 was listed as a "deuterium-modified" version of rosuvastatin, rather than a "deuterium-modified" new molecular entity. The error has been corrected in the HTML and PDF versions of the article.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Schmidt, C. First deuterated drug approved. Nat Biotechnol 35, 493–494 (2017). https://doi.org/10.1038/nbt0617-493

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0617-493

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing